http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109694357-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7eb9d223c849fb2d413ac8f7a87cd576
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
filingDate 2018-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e9e5dcd14cae98997ed84c68cfbba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1b423ac0eadc1a1a571317d67a8c123
publicationDate 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109694357-A
titleOfInvention A kind of preparation method of high-purity afatinib intermediate
abstract The present invention provides a kind of preparation method of high-purity afatinib intermediate.This method comprises: the cyclization of 2- amino -4- fluobenzoic acid, nitrification, chloro are connect 3,-chloro- 4- fluoroaniline, reaction route is as follows: .Material of the present invention is cheap, easy to operate, and product purity is high, and easy to industrialized production.
priorityDate 2018-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418910052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454017379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146469997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411285134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135798753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421903997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506

Total number of triples: 51.